tuftsin has been researched along with phosphorylcholine in 9 studies
| Studies (tuftsin) | Trials (tuftsin) | Recent Studies (post-2010) (tuftsin) | Studies (phosphorylcholine) | Trials (phosphorylcholine) | Recent Studies (post-2010) (phosphorylcholine) |
|---|---|---|---|---|---|
| 534 | 4 | 58 | 5,308 | 255 | 1,893 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S; Haq, W; Sane, SA; Shakya, N | 1 |
| Barshak, I; Bashi, T; Ben-Ami Shor, D; Bizzaro, G; Blank, M; Fridkin, M; Lachnish, J; Shoenfeld, Y | 1 |
| Barshak, I; Bashi, T; Ben-Ami Shor, D; Blank, M; Fridkin, M; Gendelman, O; Shoenfeld, Y; Versini, M; Volkov, A | 1 |
| Barshack, I; Bashi, T; Blank, M; Fridkin, M; Shoenfeld, Y; Shovman, O; Volkov, A | 1 |
| Barshack, I; Bashi, T; Ben-Ami-Shor, D; Blank, M; Eisenstein, M; Fridkin, M; Lachnish, J; Shoenfeld, Y; Shovman, O; Volkov, A | 1 |
| Blank, M; Segal, Y; Shoenfeld, Y | 1 |
| Belloni, L; Blank, M; Boiardi, L; Bonacini, M; Caruso, A; Cavazza, A; Cimino, L; Croci, S; Fontana, A; Fridkin, M; Muratore, F; Parmeggiani, M; Perry, O; Salvarani, C; Shoenfeld, Y; Soriano, A | 1 |
| Blank, M; Shoenfeld, Y | 1 |
| Abraham, L; Aharoni, R; Amital, H; Blank, M; Churilov, LP; Derevtsova, KZ; Diatlova, AS; Korneva, EA; Novikova, NS; Ostrinki, Y; Quinn, S; Segal, Y; Shoenfeld, Y; Viktorovna, TV | 1 |
2 review(s) available for tuftsin and phosphorylcholine
| Article | Year |
|---|---|
Tuftsin phosphorylcholine-a novel compound harnessing helminths to fight autoimmunity.
Topics: Animals; Autoimmune Diseases; Autoimmunity; Helminthiasis; Helminths; Humans; Inflammation; Phosphorylcholine; Tuftsin | 2018 |
Helminth-Related Tuftsin-Phosphorylcholine Compound and its Interplay with Autoimmune Diseases.
Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Helminthiasis; Helminths; Humans; Immunologic Factors; Immunomodulation; Mice; Phosphorylcholine; Tuftsin | 2019 |
7 other study(ies) available for tuftsin and phosphorylcholine
| Article | Year |
|---|---|
Augmentation of antileishmanial efficacy of miltefosine in combination with tuftsin against experimental visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hydrogen Peroxide; Immunity, Cellular; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Phagocytosis; Phosphorylcholine; Reactive Nitrogen Species; Reactive Oxygen Species; Tuftsin | 2012 |
Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.
Topics: Animals; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Phosphorylcholine; Severity of Illness Index; Tuftsin | 2015 |
Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.
Topics: Animals; Autoantibodies; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Glomerular Mesangium; Glomerulonephritis; Humans; Injections, Subcutaneous; Interleukin-2 Receptor alpha Subunit; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred NZB; Phosphorylcholine; T-Lymphocytes, Regulatory; Tuftsin | 2015 |
Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Arthritis, Experimental; B-Lymphocytes, Regulatory; CD4-Positive T-Lymphocytes; Collagen Type II; Forkhead Transcription Factors; Gene Expression; Hepatitis A Virus Cellular Receptor 1; Immunophenotyping; Injections, Subcutaneous; Interleukin-10; Interleukin-17; Interleukin-1beta; Joints; Male; Membrane Proteins; Mice; Mice, Inbred DBA; Phosphorylcholine; T-Lymphocytes, Regulatory; Tuftsin; Tumor Necrosis Factor-alpha | 2016 |
Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis.
Topics: Animals; Arthritis, Experimental; B-Lymphocytes; Disease Models, Animal; HEK293 Cells; Helminths; Humans; Interleukin-10; Interleukin-1beta; Joints; Macrophages; Male; Mice; Mice, Inbred DBA; Neuropilin-1; NF-kappa B; Phosphorylcholine; T-Lymphocytes, Regulatory; Toll-Like Receptor 4; Tuftsin | 2018 |
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cell Differentiation; Cells, Cultured; Cytokines; Dexamethasone; Drug Combinations; Female; Giant Cell Arteritis; Humans; Immunotherapy; Lymphocyte Activation; Male; Phosphorylcholine; T-Lymphocyte Subsets; Th1 Cells; Tuftsin | 2019 |
Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis.
Topics: Animals; Drug Combinations; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation Mediators; Mice; Mice, Inbred C57BL; Phosphorylcholine; Tuftsin | 2019 |